Lo Giacco Deborah, Chianese Chiara, Sánchez-Curbelo Josvany, Bassas Lluis, Ruiz Patricia, Rajmil Osvaldo, Sarquella Joaquim, Vives Alvaro, Ruiz-Castañé Eduard, Oliva Rafael, Ars Elisabet, Krausz Csilla
1] Molecular Biology Laboratory, Fundació Puigvert, Universitat Autònoma de Barcelona, Instituto de Investigaciones Biomédicas Sant Pau (IIB-Sant Pau), Barcelona, Spain [2] Andrology Service, Fundació Puigvert, Universitat Autònoma de Barcelona, Instituto de Investigaciones Biomédicas Sant Pau (IIB-Sant Pau), Barcelona, Spain.
Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
Eur J Hum Genet. 2014 Jun;22(6):754-61. doi: 10.1038/ejhg.2013.253. Epub 2013 Nov 6.
AZF microdeletion screening is routinely performed in the diagnostic work-up for male infertility; however, some issues remain debated. In this study, we provide insights into the sperm concentration cutoff value for routine testing, the predictive value of AZFc deletion for testicular sperm retrieval and the Y-background contribution to the interpopulation variability of deletion frequencies. In the Spanish population, partial AZFc rearrangements have been poorly explored and no data exist on partial duplications. In our study, 27/806 (3.3%) patients carried complete AZF deletions. All were azoo/cryptozoospermic, except for one whose sperm concentration was 2 × 10(6)/ml. In AZFc-deleted men, we observed a lower sperm recovery rate upon conventional TESE (9.1%) compared with the literature (60-80% with microTESE). Haplogroup E was the most represented among non-Spanish and hgr P among Spanish AZF deletion carriers. The analysis of AZFc partial rearrangements included 330 idiopathic infertile patients and 385 controls of Spanish origin. Gr/gr deletion, but not AZFc partial duplications, was significantly associated with spermatogenic impairment. Our data integrated with the literature suggest that: (1) routine AZF microdeletion testing could eventually include only men with ≤2 × 10(6)/ml; (2) classical TESE is associated with low sperm recovery rate in azoospermic AZFc-deleted men, and therefore microTESE should be preferred; (3) Y background could partially explain the differences in deletion frequencies among populations. Finally, our data on gr/gr deletion further support the inclusion of this genetic test in the work-up of infertile men, whereas partial AZFc duplications do not represent a risk for spermatogenic failure in the Spanish population.
无精子因子(AZF)微缺失筛查在男性不育的诊断检查中是常规进行的;然而,一些问题仍存在争议。在本研究中,我们深入探讨了常规检测的精子浓度临界值、AZFc缺失对睾丸精子提取的预测价值以及Y染色体背景对缺失频率群体间变异性的影响。在西班牙人群中,AZFc部分重排的研究较少,且不存在关于部分重复的相关数据。在我们的研究中,806例患者中有27例(3.3%)携带完全性AZF缺失。除1例精子浓度为2×10⁶/ml的患者外,其余均为无精子症/隐匿精子症患者。在AZFc缺失的男性中,我们观察到与文献报道(显微睾丸精子提取术的精子回收率为60 - 80%)相比,传统睾丸切开取精术(TESE)的精子回收率较低(9.1%)。在非西班牙裔AZF缺失携带者中,E单倍群最为常见,而在西班牙裔中hgr P最为常见。对AZFc部分重排的分析纳入了330例特发性不育患者和385例西班牙裔对照。Gr/gr缺失而非AZFc部分重复与生精功能损害显著相关。我们结合文献的数据表明:(1)常规的AZF微缺失检测最终可能只应包括精子浓度≤2×10⁶/ml的男性;(2)经典的TESE在无精子症的AZFc缺失男性中与低精子回收率相关,因此应首选显微睾丸精子提取术;(3)Y染色体背景可以部分解释不同人群间缺失频率的差异。最后,我们关于gr/gr缺失的数据进一步支持在不育男性的检查中纳入这项基因检测,而在西班牙人群中,AZFc部分重复并不代表生精失败的风险。